Beyond the Genome

Unleashing the power of AI on protein and metabolite expression


The Post-Genomic Era

The Human Genome Project (HGP) was an international scientific research project with the goal decoding the human genome and identifying genes and disease associations. Consequently, the current human genome serves as a reference to better understand the genetic contribution to human disease. 

The genome defines what is POSSIBLE. The phenome – the expressed proteins and metabolites - defines what is ACTUAL.

Unlike our genotype, our phenotype can change from day to day and determine how we feel, how we progress in health or disease, or how we will respond to changes in medications, diet or exercise.

The Phenome

Moving past the genome, we are assembling a vast library of clinically annotated, multi-omic outcome data whereby biological patterns are recognized as specific molecular phenotypes through artificial intelligence. That means we can recognize pre-disease, disease in transition as well as chronic and acute conditions and cancer. And because we have a lens into the specific biological pathways, we are able to suggest which interventions are most likely to return those pathways back to health and which are not.



On Demand Clinical Risk Report Based on Common Laboratory Results

Liquid Health CheckTM is a simple blood test giving providers, plans, employers or individuals insight into disease risk for avoidable conditions like hypertension, heart disease, diabetes, and kidney disease.  The comprehensive Clinical Risk Report produced in our CAP/CLIA certified laboratory provides absolute and relative risk along with predicted time to the disease event for both high and low risk cohorts.

That means care givers can effectively stratify populations without reliance on patient / member health risk assessments and screening, complex, time consuming and expensive data aggregation, warehousing or reporting.


Blood Phenotyping for Risk Recognition

Liquid Health BaselineTM is a phenotypical analysis for providers, plans, employers or individuals informing a comprehensive risk profile for high impact disease and events like cancers, heart disease, diabetes, preeclampsia and pre-term birth.

This highly sensitive analysis means care givers can better target interventions and monitor even subtle improvement or decline in health at the cellular level.

The gateway to health and wellness begins with a simple blood test